Why is Maitreya Medica. falling/rising?

As of 17-Nov, Maitreya Medicare Ltd's stock price is currently at 260.55, reflecting a decline of 26.0 points or 9.07%. The stock has underperformed its sector today by 11.49%, despite showing higher performance than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. Over the past week, the stock has gained 9.80%, but it has experienced a significant year-to-date decline of 22.49%. The company's ability to service debt is strong, indicated by a low Debt to EBITDA ratio of 0.30 times, and it has an attractive valuation with a Price to Book Value of 5.5. However, the stock's profits have fallen by 40% over the past year, contributing to its negative return of 21.97%.
In the broader market context, Maitreya Medicare Ltd's performance over the past week has outpaced the Sensex, which has only increased by 1.72%. However, the stock's year-to-date performance is significantly worse than the Sensex's gain of 10.02%. This disparity highlights the challenges the company faces despite some positive indicators, such as rising investor participation with a 13.82% increase in delivery volume. Overall, while there are some strengths in the company's financial metrics, the substantial drop in profits and the stock's recent underperformance relative to both its sector and the broader market are likely driving the current decline in its stock price.